BCHE and mild neurocognitive disorder: Our study sample, while mostly comprising people with mild neurocognitive disorder (MND), did not incorporate cases of HIV-associated dementia; therefore, this cholinesterase may not have been sufficiently potent to achieve an effect on subtle cognitive deficits.